Evidence map›Paper›PMID 27131803›Full record

ArticleInternational orthopaedics2017

Femoral revision surgery using a fully hydroxyapatite-coated stem: a cohort study of twenty two to twenty seven years.

Olav Reikerås

Abstract read
PubMed Publisher
In one paragraph

Article in International orthopaedics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Olav ReikeråsOrthopaedic Department, Oslo University Hospital, Rikshospitalet, 0027, Oslo, Norway. olav.reikeras@ous-hf.no.
Oslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeFemoral component revision with either cemented or proximally coated stems has been disappointing, but revision with extensively coated stems has been promising. Our purpose was to evaluate the long-term outcome using an extensively hydroxyapatite (HA)-coated stem in femoral revisions surgery.

methodsDuring 1988-1993 we performed 66 femoral revisions in 65 patients (49 women), mean age 58 (range, 28-86) years. We used a grit-blasted straight stem made of TiAl

resultsDuring follow-up, 21 patients have died. One patient had a traumatic fracture around the stem after six years, and another patient with osteoporosis developed fatigue fracture of the femoral bone after 22 years. In one patient the cup loosened after 23 years. The cup was revised, but deep infection occurred, and the patient underwent a two-stage revision of both components. Then, 12 of the revised stems were followed for more than ten years and 24 for more than 20 years. During this time only one stem was revised due to mechanical failure. This patient had a femoral defect classified to Type IV, and a proximal fracture occurred when the prosthesis was inserted. The fracture was stabilised by wires, but primary stability of the stem could not be obtained. At control examinations no patients suffered from significant thigh pain, and we noticed a low degree of proximal bone loss and a low incidence of distal bone hypertrophy.

conclusionsOur study suggests that a fully HA-coated stem in femoral revision surgery can provide reliable results for up to 27 years. The bone changes confirmed a well-fixed femoral component with a rather physiological transfer of stress from proximal to distal regions with no significant thigh pain.

Indexed as

AdultAgedAged, 80 and overArthroplasty, Replacement, HipCohort StudiesDurapatiteFemaleFemurFollow-Up StudiesHip ProsthesisHumansMaleMiddle AgedProsthesis DesignProsthesis FailureReoperationDurapatiteArthroplastyHipHydroxyapatiteRevisionStem

Identifiers

PMID27131803
OpenAlexW2343987847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.